Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 0.83 SGD -0.6% Market Closed
Market Cap: 1.6B SGD
Have any thoughts about
Raffles Medical Group Ltd?
Write Note

Raffles Medical Group Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Raffles Medical Group Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Raffles Medical Group Ltd
SGX:BSL
Cost of Revenue
-S$45.7m
CAGR 3-Years
32%
CAGR 5-Years
16%
CAGR 10-Years
4%
I
ISEC Healthcare Ltd
SGX:40T
Cost of Revenue
-S$40.4m
CAGR 3-Years
-25%
CAGR 5-Years
-13%
CAGR 10-Years
-17%
O
Oue Lippo Healthcare Ltd
SGX:5WA
Cost of Revenue
-S$36.6m
CAGR 3-Years
-100%
CAGR 5-Years
-48%
CAGR 10-Years
-7%
A
Asia Vets Holdings Ltd
SGX:5RE
Cost of Revenue
-S$1.8m
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
24%
Thomson Medical Group Ltd
SGX:A50
Cost of Revenue
-S$75.2m
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
No Stocks Found

Raffles Medical Group Ltd
Glance View

Market Cap
1.5B SGD
Industry
Health Care

In the bustling heart of Singapore, Raffles Medical Group Ltd. has established itself as a cornerstone of the healthcare sector in Asia. Founded in 1976, the company has cultivated a reputation for comprehensive medical services, seamlessly blending the professional expertise and state-of-the-art technology. From its humble origins as a two-doctor clinic, Raffles Medical has expanded into a formidable network, operating over 100 clinics and a renowned tertiary hospital in Singapore. Its operation spans across key Asian markets, including China, Vietnam, and Japan. The company’s focus on providing quality healthcare is evident in its diverse range of services, which include everything from primary care and dental clinics to more specialized services such as radiology and laboratory services. Through a blend of clinical care and innovation, Raffles Medical Group continues to meet the healthcare needs of the growing population in the region. Financially, Raffles Medical Group’s business model is multifaceted, effectively capitalizing on various revenue streams. The company derives its income from both its extensive suite of outpatient and inpatient services. Outpatient services, through its primary care clinics, offer a steady stream of revenue as these clinics handle routine check-ups, vaccinations, and chronic disease management. Inpatient services, provided mainly through Raffles Hospital in Singapore, include surgery, intensive care, and emergency care, catering to an international clientele that values the hospital’s esteemed integrated healthcare model. Additionally, the company diversifies its income with corporate health insurance services, which leverage its medical expertise to provide tailored health insurance plans, thereby enmeshing itself further into the fabric of its clientele's healthcare journey. This diversification not only strengthens the company’s financial foundation but also positions it well for growth in an industry that revolves around the constancy of human health needs.

BSL Intrinsic Value
0.92 SGD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Raffles Medical Group Ltd's Cost of Revenue?
Cost of Revenue
-45.7m SGD

Based on the financial report for Jun 30, 2024, Raffles Medical Group Ltd's Cost of Revenue amounts to -45.7m SGD.

What is Raffles Medical Group Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
4%

Over the last year, the Cost of Revenue growth was 23%. The average annual Cost of Revenue growth rates for Raffles Medical Group Ltd have been 32% over the past three years , 16% over the past five years , and 4% over the past ten years .

Back to Top